Business Description
Zota Health Care Ltd
ISIN : INE358U01012
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.49 | |||||
Debt-to-EBITDA | 4.48 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 10.17 | |||||
Beneish M-Score | -3.45 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.8 | |||||
3-Year EBITDA Growth Rate | 16.8 | |||||
3-Year FCF Growth Rate | -183.5 | |||||
3-Year Book Growth Rate | 4.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.71 | |||||
9-Day RSI | 41.88 | |||||
14-Day RSI | 43.93 | |||||
6-1 Month Momentum % | 19.53 | |||||
12-1 Month Momentum % | 77.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.87 | |||||
Quick Ratio | 1.68 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 136.35 | |||||
Days Sales Outstanding | 66.94 | |||||
Days Payable | 82.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.21 | |||||
3-Year Dividend Growth Rate | 14.5 | |||||
Forward Dividend Yield % | 0.21 | |||||
5-Year Yield-on-Cost % | 0.16 | |||||
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -1.62 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.66 | |||||
Operating Margin % | -3.75 | |||||
Net Margin % | -6 | |||||
FCF Margin % | -8.65 | |||||
ROE % | -11.25 | |||||
ROA % | -6.04 | |||||
ROIC % | -4.55 | |||||
ROC (Joel Greenblatt) % | -5.92 | |||||
ROCE % | -4.55 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 214.61 | |||||
PS Ratio | 7.33 | |||||
PB Ratio | 12.19 | |||||
Price-to-Tangible-Book | 12.62 | |||||
EV-to-EBIT | -212.05 | |||||
EV-to-EBITDA | 111.27 | |||||
EV-to-Revenue | 7.47 | |||||
EV-to-FCF | -88.07 | |||||
Price-to-Projected-FCF | 35.47 | |||||
Price-to-Net-Current-Asset-Value | 270.31 | |||||
Earnings Yield (Greenblatt) % | -0.48 | |||||
FCF Yield % | -1.21 | |||||
Forward Rate of Return (Yacktman) % | -1.67 |